Alpha Cognition Inc.
b'
Alpha Cognition Inc. (OTCQB: ACOGF) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer\'s Dementia and ALS. CEO Michael McFadden joins us to break down the types of neurodegenerative diseases that are targeted in the company\\u2019s programs.
\\xa0
'